缓解率

  • 网络ORR;pCR;CCR
缓解率缓解率
  1. 结果24例患者完全缓解率(CR)83.3%。

    Results Complete remission rate ( CR ) was 83.3 % .

  2. 治疗组总缓解率高于对照组(P<0.05);

    Total relieving rate of the cure group is higher than that of the contrast group ( P < 0 . 05 ) .

  3. 统计学分析显示,两组治疗方法比较各症状及体征的缓解率均无显著性差异(P>0.05)。

    Statistical analysis showed that comparison of two treatments to ease symptoms and signs was no significant difference in rates ( P 0.05 ) .

  4. TE方案、p53阳性者具有较高的缓解率。

    TE regimen and cases of p53 positive have a higher response rate .

  5. 总缓解率为(PR)22.58%,平均缓解时间为15.95个月。

    A partial response ( PR ) rate of 22.58 % was achieved .

  6. 总缓解率C组明显高于A组(P<0.01)和B组(P<0.05)。

    The total remissive rate of group C was markedly higher than that in group A ( P < 0.01 ) and group B ( P < 0.05 ) .

  7. 结果:治疗后TEA组心绞痛缓解率100%,心绞痛发作次数及时间均有改善。

    Results : The rate of patients chest_pain relief is 100 % after TEA and the times and the intervals of angina pectoris attack were improved .

  8. 结果:完全缓解率100%,获CR所需的中位时间42.5d。

    Result : Complete remission ( CR ) rate was 100 % . The mean time for achieving CR was 42.5 days .

  9. 结果吸附透析组患者治疗后皮肤瘙痒缓解率为85%,治疗前后比较有显著性差异(P<0.01)。

    Results In HPHD group , the remission rate of uraemia pruritus was 85 % ( 12 / 15 ), and there was a significant diffierence ( P < 0.01 ) .

  10. 5d内上腹部疼痛缓解率分别为85%和82%,(P>0.05)。

    Pain relieve rates within 5 d were 85 % and 82 % , respectively ( P > 0.05 ) .

  11. 结论MAE方案可提高老年AML的缓解率和长期无病生存率。

    Conclusion MAE protocol can improve CR rate in elderly patients of AML .

  12. 手术后内分泌缓解率与肿瘤的生长方式、术前PRL激素水平有关。

    Endocrine remission rate and tumor growth after surgery , preoperative GH hormone related .

  13. 结果本组MG患者的临床完全缓解率为45.7%,死亡2例,与危象的发生无关,再住院率为5.7%。

    A clinic complete remission rate in MG patients reached 45.7 % , readmission rate 5.7 % , 2 dead but not corresponding to the occurrence of crises .

  14. 鼻咽肿瘤缓解率也有所提高,但无统计学意义(P0.05)。

    However the increase of the complete response rate of the nasopharyngeal tumor was not significant ( P0.05 ) in group I as comparing with group ⅱ .

  15. 结论:利妥昔单抗联合CHOP方案可有效用于治疗新诊断的弥漫性大B细胞性淋巴瘤具有较高的缓解率,不良反应较少。

    Conclusion : Rituximab in combined with CHOP can be successfully applied to the therapy of initially diagnosed diffuse large B cell lymphoma , with adverse reactions .

  16. 结论CT定位使卵园孔穿刺技术不单纯依赖经验,能极大提高治疗成功率,从而提高疼痛缓解率,降低术后并发症发生率本系统的经验可以在开发设计其他相关系统时所借鉴。

    Conclusion Under CT-guide positioning , the puncture technique through the foramen ovale needs no only depend on experience . CT can greatly increase the successful rate and decrease the incidence of postoperative complications .

  17. 结论PCNA阳性表达者缓解率高,与长期预后无关。

    Conclusion The AL patients with PCNA expression were higher in remission rate , and PCNA expression was not associated with long-term prognosis .

  18. 结果腹痛、黄疸的症状缓解率两组之间差异无显著性,但单纯放疗组黄疸改善时间较短(P<0-05);

    Results Although the remission rate of jaundice and pain did not show significant difference between the two groups , patients in C + R treatment group had longer period of symptomatic remission ( P < 0.05 ) .

  19. 术后总缓解率:研究组为82.6%,对照组为20.0%(P0.01);

    The total remission rate in the study group and control group was 82 6 % and 20 % respectively ( P 0 01 ) .

  20. 结果:A组术后即刻症状缓解率平均为68%,主观满意度优良率达95%,B组术后即刻症状缓解率平均为61%,主观满意度优良率为87%。

    Result : At the time after operation , percentage of symptom relief was 68 % , perfect rate of subjective satisfaction was 95 % in cervical group , 61 % and 87 % in lumbar group .

  21. 结果:(1)症状缓解率811%,其中D组症状缓解率低于I组和H组(P<001);

    Results : ( 1 ) The symptom remission rate was 81.1 % , there were significant differences between the group DC with group D and Group H ( P < 0 01 ) .

  22. 用χ2检验比较不同吸烟量患者之间有无差异,比较不同情况的患者在缓解率及疾病控制方面有无差异,用logistic多因素回归分析了解与疾病控制率、缓解率相关的因素。

    The difference between patients with different smoking status was done by χ 2 test . Logistic regression was used for multivariate analysis of disease control rates and response rates .

  23. 结果:在可评价病例中,8例(16.0%)获PR,第一线及第二线病人缓解率分别为12.0%及20.0%,中位缓解时间5.42个月。

    Results : The response rate of the whole group was 16.0 % ( 12.0 % for first line and 20.0 % for second line ) .

  24. 临床未发生明显副作用.37例恶性肿瘤IL-2治疗组总缓解率86.5%。

    The overall response rate that 37 patients malignant tumor group with IL-2 treated was higher than 37 patients malignant tumor group with IL-2 not treated .

  25. 结果:总缓解率71.4%(11例CR,14例PR)。缓解期3~35月,中位缓解期24月。

    Results : Overall response rate was 71.4 % ( 11 CR and 14 PR ) with a median duration of 24 months ( range : 3 - 35 ) .

  26. 初治与复发APL的完全缓解率达80% ̄90%。

    The CR ( complete remission ) rate of new diagnosis and relapsed APL were 80 % ~ 90 % .

  27. 传统的放化疗治疗AML完全缓解率较低,易复发。

    The complete remission rate is significantly lower and relapsed quickly in the AML cases that were treated by traditional chemo-therapy and radio-therapy .

  28. 11例CT定位穿刺均一次成功,PVP技术操作成功率100%,疼痛完全缓解率90%。

    In 11 cases the localization and puncture was successful for one try . The success rate of PVP was 100 % , the release of pain was obtained in 90 % .

  29. 在一定范围,其作用随时间和浓度增加而增强。雄黄是复方青黛片治疗APL取得高缓解率的中药成分。

    And the red orpiment is responsible for the high CR rate of APL induced by the composite indigo naturalis tablets .

  30. 结果治疗组患者腹痛、腹泻、便秘等症状缓解率及总有效率均明显优于对照组(P0.05),并未观察到任何副作用。

    RESULTS Lysis rate of abdominal pain , diarrhea and or constipation and the total effective rate in treatment group was markedly superior to control group ( P0 05 ), no side-effect was observed .